Amaxa GmbH

amaxa develops systems for non-viral gene transfer into difficult to transfect and primary cells. As the world leader in transfection technologies, we enable the transfection of virtually any construct into any cell, and the ability to do so in high throughput. amaxa also offers outsourced Transfection Services and Stable Clone generation for industry. This is especially advantageous for pharmaceuticals performing high throughput screening. Reagents and Services are available cGMP regulated if necessary.